technetium

DRUG2 trials

Sponsors

Astellas Pharma Inc, Region Örebro County

Conditions

Coronary Artery Disease (CAD)Opioid Induced Swallowing Disorders

Phase 3

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

CompletedNCT00826280

Astellas Pharma IncCoronary Artery Disease (CAD)

Start: 2009-03-24End: 2010-07-15Updated: 2024-12-03

Phase 4

Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration

CompletedNCT01495377

Region Örebro CountyOpioid Induced Swallowing Disorders

Start: 2012-01-31End: 2012-05-31Updated: 2012-08-22

Related Papers

Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.

2010-11-177 citations